Real-world check confirms venetoclax safety and effectiveness in AML patients

NCT ID NCT04826523

First seen Dec 15, 2025 · Last updated May 05, 2026 · Updated 21 times

Summary

This study tracked 150 adults in South Korea with acute myeloid leukemia (AML) who were prescribed venetoclax tablets for the first time. Researchers monitored side effects and how well the drug controlled the cancer over about 7 months. The goal was to see how venetoclax works in everyday medical practice, not just in strict research settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chonnam National University Hwasun Hospital /ID# 257478

    Hwasun-gun, Jeonranamdo, 58128, South Korea

  • Gachon University Gil Medical Center /ID# 239008

    Incheon, Gyeonggido, 21565, South Korea

  • Korea University Anam Hospital /ID# 231022

    Seoul, Seoul Teugbyeolsi, 02841, South Korea

  • Kosin University Gospel Hospital /ID# 257399

    Busan, Busan Gwang Yeogsi, 49267, South Korea

  • Kyungpook National University Hospital /ID# 257398

    Daegu, Daegu Gwang Yeogsi, 41944, South Korea

  • Pusan National University Hospital /ID# 239010

    Busan, Busan Gwang Yeogsi, 49241, South Korea

  • Samsung Medical Center /ID# 239009

    Seoul, Seoul Teugbyeolsi, 06351, South Korea

  • Seoul National University Hospital /ID# 257477

    Seoul, Seoul Teugbyeolsi, 03080, South Korea

  • Yeungnam University Medical Center /ID# 239007

    Daegu, 42415, South Korea

  • Yonsei University Health System Severance Hospital /ID# 239006

    Seoul, 03722, South Korea

Conditions

Explore the condition pages connected to this study.